AVAI (Avai Bio) Beginning Cash Position: $0.09 Mil (As of Dec. 2025)


AVAI Avai Bio Inc AVAI
24 GF Score
Price $0.15
! 3 Warning Signs
View Full Analysis

What is Avai Bio Beginning Cash Position?

Avai Bio AVAI -6.27% 24 Beginning Cash Position is $0.09 Mil as of Dec. 2025. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

Avai Bio's Beginning Cash Position for the quarter that ended in Dec. 2025 was $0.09 Mil.

Avai Bio's quarterly Beginning Cash Position declined from Jun. 2025 ($0.08 Mil) to Sep. 2025 ($0.01 Mil) but then increased from Sep. 2025 ($0.01 Mil) to Dec. 2025 ($0.09 Mil).

Avai Bio's annual Beginning Cash Position increased from Mar. 2023 ($0.03 Mil) to Mar. 2024 ($0.11 Mil) but then declined from Mar. 2024 ($0.11 Mil) to Mar. 2025 ($0.00 Mil).

Avai Bio Beginning Cash Position Related Terms

Avai Bio Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Avai Bio's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avai Bio Beginning Cash Position Chart

Avai Bio Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beginning Cash Position
Get a 7-Day Free Trial 0.03 0.06 0.03 0.11 0.00

Avai Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.08 0.01 0.09
AVAI
24GF Score
Avai Bio Inc AVAI
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avai Bio Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.09 Mil mean?
Avai Bio (AVAI) has a Beginning Cash Position of $0.09 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Avai Bio and its competitors.
Is Avai Bio's Beginning Cash Position too high?
Avai Bio's current Beginning Cash Position is $0.09 Mil. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's Beginning Cash Position compare to IPM and RCT?
Avai Bio's Beginning Cash Position of $0.09 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Software company?
A good Beginning Cash Position depends on the Software industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Avai Bio and its competitors. Avai Bio's current Beginning Cash Position is $0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current Beginning Cash Position of $0.09 Mil. The current Beginning Cash Position is $0.09 Mil. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Avai Bio (AVAI), the current Beginning Cash Position is $0.09 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avai Bio Business Description

Address 5348 Vegas Drive, Las Vegas, NV, USA, 89108
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score

Get the complete analysis for AVAI

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price